Phenomics Health
Plymouth, US · 1 known investors
Find your way into Phenomics Health
344 people in our graph share verified history with the Phenomics Health team — schools, employers, funds. One of them is your warm intro.
Douglas Lemott Jr.unlockedknows Gerry Higgins · together at Office of the Secretary of Defense (overlapped)
×2knows the team · via Defense Advanced Research Projects Agency (DARPA)
×3knows the team · via Roche
knows the team · via MedStar Health
×2knows the team · via Central Intelligence Agency
×2knows the team · via Western Michigan University
Phenomics Health builds a medication-response intelligence platform that combines high-complexity clinical laboratory testing, pharmacogenomics, pharmacometabolomics, and AI-enabled analytics to support precision prescribing and medication decisions. It serves clinicians, payors, providers, and life-sciences partners in the precision-medicine space.
Founders & leadership
BD
Brian D. AtheyCo-founder
DJ
Daniel JasewiczinCompany Leadership (Strategy & Commercialization)Daniel Jasewicz is a healthcare executive with experience in precision medicine, pharmacogenomics, and AI-enabled clinical diagnostics platforms. He has led organizations building EHR-integrated diagnostic systems and decision-support tools in regulated laboratory environments, and currently leads strategy and commercialization at Phenomics Health.
GH
Gerry HigginsinScientific Strategy LeadGerry Higgins is Vice President at Phenomics Health, where he applies expertise in pharmacogenomics and disease genetics to precision medicine. He has over 35 years of experience in biomedical research and clinical informatics, and holds academic roles at PhenomicsAI and the University of Michigan Medical School.
AA
Alex AdeinTechnology & Data Science LeadAlex Ade is Technology & Data Science Lead at Phenomics Health, where he focuses on building data and AI-enabled platforms for precision medicine. He has a background in software engineering and systems design, with experience leading the architecture and delivery of scalable platforms in healthcare settings.
PW
Pamela WeirNamed on SEC filing
LW
Lew WallaceNamed on SEC filing
FD
F. David ParkerNamed on SEC filing
JM
Jarrett MillsapsNamed on SEC filing
JS
James S. BurnsFounder
WC
Wenbing CheninLaboratory Director
Investors · 1
Reported raises · per SEC filings
Form D private placements$11.5M disclosed across 1 round · 2022
▶$11.5MraisedOct 2022 · 33 investors · OtherRule 506(b)
▶$11.5MraisedOct 2022 · 33 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Pamela WeirDirector
- Lew WallaceDirector
- F. David ParkerDirector
- Jarrett MillsapsDirector
- James S. BurnsExecutive Officer, Director
- Offering amount
- $19.5M
- Amount sold
- $11.5M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 7
by search overlapGenomics Plc18 shared keywordsGenomics builds a genotype-phenotype database and genetic risk-prediction tools used to support pharmaceutical drug discovery and clinical trials, as well as population health management and clinical decision support for healthcare providers. It serves life sciences companies and healthcare systems through its Life Sciences and Health & Wellness divisions.
Phinomics14 shared keywordsPhinomics is a cancer drug discovery platform that captures extrachromosomal circular DNA (the "Circulome") at high resolution from matched tumor and normal patient samples, integrating it with DNA, RNA, epigenetics, and proteomics into a multi-omic knowledge graph. It applies explainable AI to this data to identify novel therapeutic targets, resistance mechanisms, and patient stratification biomarkers for oncology therapeutics development.
Phenomic AI14 shared keywordsPhenomic AI is a biotech company developing therapies for solid tumors using a machine-learning-powered transcriptomics platform that analyzes single-cell RNA data to identify drug targets and understand tumor biology. The company develops antibody-based therapies informed by its analysis of cell-cell interactions in tumor microenvironments, with current programs targeting stromal and immune components of difficult-to-treat cancers.
Phenomix Sciences10 shared keywordsPhenomix Sciences applies data analytics and patient data to enable precision obesity medicine, aiming to guide treatment decisions for anti-obesity medications such as GLP-1s and reduce care costs. Its platform-based approach targets the healthcare market for obesity treatment.
NeoGenomics9 shared keywordsNeoGenomics develops diagnostic tests and tools for cancer care, including tests for immunotherapy response monitoring, therapy selection, and minimal residual disease detection.
Tagomics9 shared keywordsTagomics develops multimodal technologies for precision medicine and next-generation diagnostics. The company is based in Cambridge and focuses on improving patient outcomes through advanced diagnostic technologies.
Helix7 shared keywordsHelix is a population genomics company that provides an end-to-end platform to integrate genomic data into clinical care, research, and therapeutic development. It partners with health systems, providers, payers, life sciences organizations, and patients to enable genetic screening and personalized healthcare at scale.
Companies competing with Phenomics Health for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Phenomics Health do?
- Phenomics Health builds a medication-response intelligence platform that combines high-complexity clinical laboratory testing, pharmacogenomics, pharmacometabolomics, and AI-enabled analytics to support precision prescribing and medication decisions. It serves clinicians, payors, providers, and life-sciences partners in the precision-medicine space.
- Who founded Phenomics Health?
- Phenomics Health was founded by Brian D. Athey.
- Who are Phenomics Health's investors?
- Phenomics Health's investors include Solas BioVentures.
- How much funding has Phenomics Health raised?
- Phenomics Health has disclosed $11.5M raised across 1 round.
- Where is Phenomics Health headquartered?
- Phenomics Health is headquartered in Plymouth, US.